Salvage therapy with "Dara-KDT-P(A)CE" in heavily pretreated, high-risk, proliferative, relapsed/refractory multiple myeloma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Hematological Oncology (2022) 40:2, 202-211. https://doi.org/10.1002/hon.2949
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2022
- Creator
-
Zhou, Xiang
Ruckdeschel, Anna
Peter, Jessica
Böckle, David
Hornburger, Hannah
Danhof, Sophia
Steinhardt, Maximilian Johannes
Heimeshoff, Larissa
Einsele, Hermann
Kortüm, Klaus Martin
Rasche, Leo
- DOI
-
10.1002/hon.2949
- URN
-
urn:nbn:de:bvb:20-opus-257495
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:50 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhou, Xiang
- Ruckdeschel, Anna
- Peter, Jessica
- Böckle, David
- Hornburger, Hannah
- Danhof, Sophia
- Steinhardt, Maximilian Johannes
- Heimeshoff, Larissa
- Einsele, Hermann
- Kortüm, Klaus Martin
- Rasche, Leo
- Universität Würzburg
Time of origin
- 2022
Other Objects (12)
Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma
Sorafenib in patients with refractory or recurrent multiple myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Efficacy of dose-reduced Ienalidomide in patients with refractory or recurrent multiple myeloma
Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Salvage
Functional analysis of oncogenic lesions in multiple myeloma with potential significance for refractory disease
A GRP78-directed monoclonal antibody recaptures response in refractory multiple myeloma with extramedullary involvement
Modified salvage endoscopic combined intrarenal surgery in a single functional kidney with refractory staghorn stone
Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone
Carfilzomib based treatment strategies in the management of relapsed/refractory multiple myeloma with extramedullary disease
Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma
Sorafenib in patients with refractory or recurrent multiple myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Efficacy of dose-reduced Ienalidomide in patients with refractory or recurrent multiple myeloma
Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Salvage
Functional analysis of oncogenic lesions in multiple myeloma with potential significance for refractory disease
A GRP78-directed monoclonal antibody recaptures response in refractory multiple myeloma with extramedullary involvement
Modified salvage endoscopic combined intrarenal surgery in a single functional kidney with refractory staghorn stone
Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone
Carfilzomib based treatment strategies in the management of relapsed/refractory multiple myeloma with extramedullary disease
Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma
Sorafenib in patients with refractory or recurrent multiple myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Efficacy of dose-reduced Ienalidomide in patients with refractory or recurrent multiple myeloma
Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Salvage
Functional analysis of oncogenic lesions in multiple myeloma with potential significance for refractory disease
A GRP78-directed monoclonal antibody recaptures response in refractory multiple myeloma with extramedullary involvement
Modified salvage endoscopic combined intrarenal surgery in a single functional kidney with refractory staghorn stone
Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone